Lithuanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

gelonin/vėžys

Nuoroda įrašoma į mainų sritį
StraipsniaiKlinikiniai tyrimaiPatentai
10 rezultatus

VEGF-gelonin for targeting the vasculature of solid tumors

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to methods and compositions for targeting the vasculature of solid tumors using immunological and growth factor-based reagents. In particular aspects, antibodies carrying diagnostic or therapeutic agents

Deimmunized gelonin molecules and therapies

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to the field of molecular biology and recombinant protein production. More particularly, it concerns gelonin polypeptides with decreased immunogenicity and cell-targeting constructs comprising said less

ImmunoConjucates for cancer diagnosis and therapy

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND 1. Field of the Invention The present invention relates generally to the field of immunoconjugates and, more particularly, to the use of immunoconjugates in the diagnosis and treatment of cancer. The invention also relates to the treatment of breast and cervical carcinoma with cytotoxic

Method for treating tumors with a toxin

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND OF THE INVENTION 1. Field of the Invention The instant invention is a novel method for treating tumors with a toxin. More specifically, the present method involves preliminarily immunizing a patient with a toxin vaccine containing a cytotoxic cancerostatic toxin or toxin surrogate to

Method for treating tumors with a toxin

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND OF THE INVENTION 1. Field of the Invention The instant invention is a novel method for treating tumors with a toxin. More specifically, the present method involves preliminarily immunizing a patient with a toxin vaccine containing a cytotoxic cancerostatic toxin or toxin surrogate to

Polynucleotides encoding gelonin sequences

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
The present invention generally relates to materials useful as components of cytotoxic therapeutic agents. More particularly, the invention relates to ribosome-inactivating proteins, to analogs of ribosome-inactivating proteins, to polynucleotides encoding such proteins and analogs, some of which

Fusion proteins and polynucleotides encoding gelonin sequences

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION The present invention generally relates to materials useful as components of cytotoxic therapeutic agents. More particularly, the invention relates to ribosome-inactivating proteins, to analogs of ribosome-inactivating proteins, to polynucleotides encoding such proteins and

Method for treating cancer

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION The present invention generally relates to methods for sterilizing animals and to methods for medically treating certain sex hormone related diseases such as, for example, cancer of the breast or prostate. More particularly, this invention relates to sterilization and medical

Materials comprising and methods of preparation and use for ribosome-inactivating proteins

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND The present invention relates, in general, to materials useful as components of cytotoxic therapeutic agents. More particularly, the invention relates to polynucleotides encoding ribosome-inactivating proteins, to polynucleotides encoding analogs of ribosome-inactivating proteins

Vascular endothelial growth factor fusion constructs used to inhibit osteoclastogenesis

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to the fields of cancer research and targeted therapy. More specifically, the present invention relates to fusion constructs comprising an isoform of vascular endothelial growth factor and uses of such
Prisijunkite prie mūsų
„Facebook“ puslapio

Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu

  • Dirba 55 kalbomis
  • Žolelių gydymas, paremtas mokslu
  • Vaistažolių atpažinimas pagal vaizdą
  • Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
  • Skaitykite mokslines publikacijas, susijusias su jūsų paieška
  • Ieškokite vaistinių žolelių pagal jų poveikį
  • Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus

Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais

Google Play badgeApp Store badge